![Robert Ashley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Ashley
Direktor/Vorstandsmitglied bei
Rowpar Pharmaceuticals, Inc.
Profil
Robert A. Ashley is currently the Director at Rowpar Pharmaceuticals, Inc. He previously held positions such as Chairman, President & CEO at AmpliMed Corp., Director-Strategic Product Planning at Bristol Myers Squibb Co., Director at IMCOR Pharmaceutical Co., Senior Vice President-Commercial Development at CollaGenex Pharmaceuticals, Inc., Manager-National Sales at GE Healthcare Ltd. (United Kingdom), Chief Scientific Officer & Executive VP at Vital Therapies, Inc., and Chief Technical Officer & Executive VP at Immunic, Inc. Ashley is a graduate of the University of Oxford.
Aktive Positionen von Robert Ashley
| Unternehmen | Position | Beginn |
|---|---|---|
Rowpar Pharmaceuticals, Inc.
 Rowpar Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Makes and markets oral care products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Ashley
| Unternehmen | Position | Ende |
|---|---|---|
Vital Therapies, Inc.
 Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Technik-/Wissenschafts-/F&E-Leiter | 12.04.2019 |
| IMMUNIC, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2019 |
AmpliMed Corp.
 AmpliMed Corp. Pharmaceuticals: MajorHealth Technology Provides biotechnological services | Vorstandsvorsitzender | 01.03.2007 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Corporate Officer/Principal | 01.12.2003 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.09.1994 |
Ausbildung von Robert Ashley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Health Technology |
IMCOR Pharmaceutical Co.
 IMCOR Pharmaceutical Co. Medical SpecialtiesHealth Technology Develops medical imaging pharmaceutical products | Health Technology |
AmpliMed Corp.
AmpliMed Corp. Pharmaceuticals: MajorHealth Technology Provides biotechnological services | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology Provides transformational medical technologies and services | Health Technology |
Rowpar Pharmaceuticals, Inc.
Rowpar Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Makes and markets oral care products | Health Technology |
Immunic, Inc.
 Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
